Research and Development

The Research and Development team at Equillium is dedicated to pioneering new biotechnological solutions to treat severe autoimmune and inflammatory diseases. Led by the Chief Scientific Officer and Vice President of Research, the team conducts cutting-edge scientific research, manages laboratory operations, and collaborates closely with the clinical development and drug safety divisions to advance innovative therapies from concept through to clinical trials.